title: Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab.
authors.affiliation: Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, South Carolina.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
authors.forename: Scott D
authors.initials: SD
authors.lastname: Newsome
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
authors.forename: Kenneth R
authors.initials: KR
authors.lastname: Carson
mesh_terms: D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*
chemical_list: D018796:Immunoconjugates